Adagene新旭医药
Biotech/Healthcare
Xinxu, founded in 2015, focuses on neurodegenerative diseases. With a leading drug screening platform and technology, it develops large-molecule and small-molecule therapeutics as well as related imaging diagnostic tracers targeting misfolded protein aggregates in the brain.
Funding Rounds
- RaisedFunding amount requires an account.